本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sarepta Therapeutics

17.44
-0.4100-2.30%
盘前:17.510.0700+0.40%04:52 EDT
成交量:328.28万
成交额:5,764.65万
市值:18.41亿
市盈率:-13.25
高:18.14
开:17.88
低:17.30
收:17.85
52周最高:24.68
52周最低:14.68
股本:1.06亿
流通股本:9,905.26万
量比:1.15
换手率:3.31%
股息:- -
股息率:- -
每股收益(TTM):-1.3161
每股收益(LYR):-7.1300
净资产收益率:-9.48%
总资产收益率:-1.13%
市净率:1.21
市盈率(LYR):-2.45

数据加载中...

2026/09/24

重要事件披露

Form 8-K - Current report
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/31

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/27

重要事件披露

Form 8-K - Current report
2026/06/04

重要事件披露

Form 8-K - Current report
2026/06/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/25

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report